a year ago
VKTX
AnalystsJay OlsonJay Olson's Stock Forecasts
AnalystsJay Olson
Analyst Ranking
Top 8%
#361 out of 4995 analysts
Average Return
+10.8%
Win Rate
43%92 out of 214
Risk vs Reward
Poor
Good
Jay Olson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +578.03% | $2.64 | $17.90 | 2022-05-12 - 2023-05-12 | Buy |
89bio IncETNB | +450.31% | $3.22 | $17.72 | 2022-06-29 - 2023-06-29 | Buy |
Viking Therapeutics IncVKTX | +439.77% | $15.44 | $83.34 | 2023-03-27 - 2024-03-27 | Buy |
Madrigal Pharmaceuticals IncMDGL | +365.01% | $64.44 | $299.65 | 2022-05-09 - 2023-05-09 | Buy |
Prothena Corp Public Ltd CoPRTA | +357.12% | $12.08 | $55.22 | 2020-07-08 - 2021-07-08 | Buy |
Jay Olson Analyst Color
Get additional color on Jay Olson's coverage of popular stocks
a year ago
VKTX
a year ago
VKTX
2 years ago
VKTX
Jay Olson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bicycle Therapeutics PLCBCYC | 4 | Buy | $44.00 | +519.72% | Maintains | 12 days ago |
Mind Medicine IncMNMD | 1 | Buy | $25.00 | +145.34% | Reinstates | 19 days ago |
Atai Life Sciences NvATAI | 1 | Buy | $14.00 | +206.35% | Initiates Coverage On | 25 days ago |
Praxis Precision Medicines IncPRAX | 2 | Buy | $115.00 | +135.75% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 12 | Hold | $22.00 | -14.53% | Maintains | 2 months ago |
Tvardi Therapeutics IncTVRD | 1 | Buy | $65.00 | +131.73% | Initiates Coverage On | 3 months ago |
Jasper Therapeutics IncJSPR | 5 | Buy | $65.00 | +2,118.43% | Maintains | 3 months ago |
Inovio Pharmaceuticals IncINO | 3 | Buy | $13.00 | +563.27% | Maintains | 3 months ago |
Revolution Medicines IncRVMD | 9 | Buy | $75.00 | +102.65% | Maintains | 4 months ago |
Immuneering CorpIMRX | 2 | Buy | $21.00 | +329.45% | Maintains | 4 months ago |
Nektar TherapeuticsNKTR | 6 | Buy | $90.00 | +232.96% | Upgrades | 5 months ago |
Denali Therapeutics IncDNLI | 4 | Buy | $42.00 | +171.14% | Maintains | 6 months ago |
Prothena Corp Public Ltd CoPRTA | 11 | Buy | $62.00 | +606.96% | Maintains | 7 months ago |
Exelixis IncEXEL | 6 | Hold | $33.00 | -14.57% | Downgrades | 7 months ago |
Intellia Therapeutics IncNTLA | 9 | Buy | $40.00 | +280.23% | Maintains | 7 months ago |
Q32 Bio IncQTTB | 2 | Buy | $20.00 | +947.12% | Maintains | 8 months ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $30.00 | +321.94% | Initiates Coverage On | 9 months ago |
Terns Pharmaceuticals IncTERN | 2 | Buy | $20.00 | +188.60% | Maintains | 9 months ago |
Biogen IncBIIB | 20 | Buy | $255.00 | +83.05% | Maintains | 10 months ago |
Sage Therapeutics IncSAGE | 7 | Hold | $8.00 | -7.83% | Maintains | 10 months ago |
Incyte CorpINCY | 10 | Buy | $82.00 | -3.57% | Maintains | 10 months ago |
Madrigal Pharmaceuticals IncMDGL | 8 | Buy | $350.00 | -15.60% | Maintains | 10 months ago |
Galecto IncGLTO | 4 | Buy | $10.00 | +199.40% | Maintains | 10 months ago |
Viking Therapeutics IncVKTX | 8 | Buy | $138.00 | +430.77% | Reiterates | a year ago |
Marinus Pharmaceuticals IncMRNS | 6 | Buy | $6.00 | +990.91% | Upgrades | a year ago |
Gain Therapeutics IncGANX | 1 | Buy | $8.00 | N/A | Assumes | a year ago |
Amgen IncAMGN | 17 | Buy | $380.00 | N/A | Maintains | a year ago |
Neurocrine Biosciences IncNBIX | 12 | Buy | $219.00 | N/A | Maintains | a year ago |
Editas Medicine IncEDIT | 6 | Hold | $12.00 | N/A | Maintains | a year ago |
Voyager Therapeutics IncVYGR | 5 | Buy | $18.00 | N/A | Maintains | a year ago |
Sutro Biopharma IncSTRO | 5 | Buy | $10.00 | N/A | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 6 | Buy | $95.00 | N/A | Maintains | a year ago |
Skye Bioscience IncSKYE | 1 | Buy | $25.00 | N/A | Initiates Coverage On | a year ago |
Ionis Pharmaceuticals IncIONS | 3 | Buy | $75.00 | N/A | Maintains | a year ago |
Cognition Therapeutics IncCGTX | 4 | Buy | $9.00 | N/A | Maintains | a year ago |
Biovie IncBIVI | 4 | Buy | $500.00 | N/A | Maintains | 2 years ago |
Enanta Pharmaceuticals IncENTA | 7 | Hold | $21.00 | N/A | Maintains | 2 years ago |
Immunogen IncIMGN | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Mirati Therapeutics IncMRTX | 7 | Buy | $62.00 | N/A | Maintains | 2 years ago |
Cymabay Therapeutics IncCBAY | 3 | Buy | $16.00 | N/A | Maintains | 2 years ago |
89bio IncETNB | 4 | Buy | $30.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 4 | Buy | $280.00 | N/A | Reiterates | 2 years ago |
Seagen IncSGEN | 8 | Buy | $229.00 | N/A | Maintains | 2 years ago |
Cincor Pharma IncCINC | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Ayala Pharmaceuticals IncAYLA | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Relmada Therapeutics IncRLMD | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Sierra Oncology IncSRRA | 2 | Hold | $55.00 | N/A | Downgrades | 3 years ago |
Focus Financial Partners IncFOCS | 1 | Buy | $71.00 | N/A | Maintains | 4 years ago |
Korro Bio IncKRRO | 2 | Buy | $20.00 | N/A | Maintains | 4 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | $46.00 | N/A | Downgrades | 5 years ago |
Tempest Therapeutics IncTPST | 1 | Hold | $2.00 | N/A | Downgrades | 5 years ago |
Mediwound LtdMDWD | 1 | Buy | $84.00 | N/A | Maintains | 7 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $2,520.00 | N/A | Maintains | 8 years ago |
Medicines CoMDCO | 2 | Buy | N/A | N/A | Upgrades | 8 years ago |
Neuroderm LtdNDRM | 2 | Buy | $42.00 | N/A | Upgrades | 8 years ago |
Therapeuticsmd IncTXMD | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.